Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maurizio Callari

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Genomics|August 2, 2021
Mechanisms of responsiveness to and resistance against trabectedin in murine models of human myxoid liposarcomaLaura Mannarino, Ilaria Craparotta, Sara Ballabio, et al.
Genomics|September 18, 2021
Corrigendum to "Mechanisms of responsiveness to and resistance against trabectedin in murine models of human myxoid liposarcoma" [Genomics Volume 113, Issue 5, September 2021, Pages 3439-3448]Laura Mannarino, Ilaria Craparotta, Sara Ballabio, et al.
Genome Medicine|January 6, 2019
Next Generation-Targeted Amplicon Sequencing (NG-TAS): an optimised protocol and computational pipeline for cost-effective profiling of circulating tumour DNAMeiling Gao, Maurizio Callari, Emma Beddowes, et al.
Oncotarget|December 25, 2014
By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapyAnnalisa Petrelli, Rosachiara Carollo, Marilisa Cargnelutti, et al.
Oncotarget|August 28, 2019
Correction: By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapyAnnalisa Petrelli, Rosachiara Carollo, Marilisa Cargnelutti, et al.
Radiology and Oncology|February 16, 2020
Molecular heterogeneity in breast carcinoma cells with increased invasive capacitiesGiulia Negro, Bertram Aschenbrenner, Simona Kranjc Brezar, et al.
Molecular Oncology|April 22, 2025
Detecting homologous recombination deficiency for breast cancer through integrative analysis of genomic dataRong Zhu, Katherine Eason, Suet-Feung Chin, et al.
Cancer Medicine|March 20, 2015
Molecular portrait of breast cancer in China reveals comprehensive transcriptomic likeness to Caucasian breast cancer and low prevalence of luminal A subtypeXiaoyan Huang, Matteo Dugo, Maurizio Callari, et al.
Cell Reports Methods|May 27, 2026
Real-time cell viability monitoring for high-throughput drug screening using tumor xenograft-derived cellsElham Esmaeilishirazifard, Daniel Guerrero-Romero, Allan J W Lui, et al.
Oncogene|October 27, 2021
Clonal populations of a human TNBC model display significant functional heterogeneity and divergent growth dynamics in distinct contextsHendrik J Kuiken, Sabin Dhakal, Laura M Selfors, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Genomics|August 2, 2021
Mechanisms of responsiveness to and resistance against trabectedin in murine models of human myxoid liposarcomaLaura Mannarino, Ilaria Craparotta, Sara Ballabio, et al.
Genomics|September 18, 2021
Corrigendum to "Mechanisms of responsiveness to and resistance against trabectedin in murine models of human myxoid liposarcoma" [Genomics Volume 113, Issue 5, September 2021, Pages 3439-3448]Laura Mannarino, Ilaria Craparotta, Sara Ballabio, et al.
Genome Medicine|January 6, 2019
Next Generation-Targeted Amplicon Sequencing (NG-TAS): an optimised protocol and computational pipeline for cost-effective profiling of circulating tumour DNAMeiling Gao, Maurizio Callari, Emma Beddowes, et al.
Oncotarget|December 25, 2014
By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapyAnnalisa Petrelli, Rosachiara Carollo, Marilisa Cargnelutti, et al.
Oncotarget|August 28, 2019
Correction: By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapyAnnalisa Petrelli, Rosachiara Carollo, Marilisa Cargnelutti, et al.
Radiology and Oncology|February 16, 2020
Molecular heterogeneity in breast carcinoma cells with increased invasive capacitiesGiulia Negro, Bertram Aschenbrenner, Simona Kranjc Brezar, et al.
Molecular Oncology|April 22, 2025
Detecting homologous recombination deficiency for breast cancer through integrative analysis of genomic dataRong Zhu, Katherine Eason, Suet-Feung Chin, et al.
Cancer Medicine|March 20, 2015
Molecular portrait of breast cancer in China reveals comprehensive transcriptomic likeness to Caucasian breast cancer and low prevalence of luminal A subtypeXiaoyan Huang, Matteo Dugo, Maurizio Callari, et al.
Cell Reports Methods|May 27, 2026
Real-time cell viability monitoring for high-throughput drug screening using tumor xenograft-derived cellsElham Esmaeilishirazifard, Daniel Guerrero-Romero, Allan J W Lui, et al.
Oncogene|October 27, 2021
Clonal populations of a human TNBC model display significant functional heterogeneity and divergent growth dynamics in distinct contextsHendrik J Kuiken, Sabin Dhakal, Laura M Selfors, et al.
Pageof 7